Denali Therapeutics, Inc. (DNLI)
17.52
-0.48
(-2.64%)
USD |
NASDAQ |
Jan 20, 16:00
17.52
0.00 (0.00%)
After-Hours: 19:20
Denali Therapeutics Market Cap: 2.735B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enovis Corp. | 1.318B |
| Masimo Corp. | 7.672B |
| Protalix Biotherapeutics, Inc. | 164.46M |
| Twist Bioscience Corp. | 2.553B |
| AIM ImmunoTech, Inc. | 3.456M |
Market Cap Related Metrics
| PEG Ratio | -1.135 |
| Price to Book Value | 2.953 |
| Price | 17.52 |
| Earnings Yield | -16.62% |
| PEGY Ratio | -1.135 |